Two Sigma Investments
CLVS

Two Sigma Investments’s Clovis Oncology, Inc. CLVS Stock Holding History

Two Sigma Investments’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-78,700
Closed -$6.49M – 3540
2017
Q3 		$6.49M Buy
+78,700
New +$6.24M 0.02% 690

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Investments's CLVS Position: Q3 2022 in Review

Two Sigma Investments sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 74,712 shares — an estimated $134K sold.

Two Sigma Investments first reported a position in CLVS in Q2 2013 and held it in 12 quarters. The position peaked at $35.4M in Q1 2017. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • Two Sigma Investments reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Investments sold 74,712 Clovis Oncology, Inc. shares in Q3 2022, an estimated $134K.
  • Two Sigma Investments first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 12 quarters.
  • Two Sigma Investments's Clovis Oncology, Inc. position peaked at $35.4M in Q1 2017.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.